Resultados de la búsqueda 1-10 of 14915 for breast

  1. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease. Rochester, Minn., Jacksonville, Fla. The purpose of this study is to to ...

  2. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    ... Breast Cancer Risk Assessment Tool (BCRAT) or Tyrer-Cuzick (IBIS) score will aid women at risk of breast cancer in making a decision to take (or not take) ...

  3. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease. Rochester, Minn., Jacksonville, Fla. The purpose of this study is to to ...

  4. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment Tool ...

  5. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease. Rochester, Minn., Jacksonville, Fla. The purpose of this study is to to ...

  6. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to estimate the circulating tumor DNA (ctDNA)detection rate and mutational load in breast cancer patients with ...

  7. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    ... Breast Cancer Risk Assessment Tool (BCRAT) or Tyrer-Cuzick (IBIS) score will aid women at risk of breast cancer in making a decision to take (or not take) ...

  8. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer.

  9. Aumento de senos - Mayo Clinic

    Breast implant surgery. U.S. Food and Drug Administration. https://www.fda.gov/medical-devices/breast-implants/breast-implant-surgery. Accessed March 7 ...

  10. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer.